Pump-controlled retrograde trial off extracorporeal membrane oxygenation.

Area of Science:

• Cardiology
• Pediatric Critical Care
• Cardiovascular Surgery

Background:

• Venoarterial extracorporeal membrane oxygenation (VA-ECMO) weaning strategies lack standardization, posing challenges for patients with complex physiologies and borderline hemodynamics.
• A reliable and safe method for decannulation from VA-ECMO is crucial for optimizing patient outcomes.

Purpose of the Study:

• To introduce and evaluate a standardized pump-controlled retrograde trial off protocol for VA-ECMO weaning.
• To assess the feasibility, reliability, and validity of this protocol in predicting successful separation from VA-ECMO.

Main Methods:

• A step-by-step approach for the pump-controlled retrograde trial off protocol was developed and demonstrated.
• The protocol was applied to a neonate with myocarditis, borderline myocardial function, and mitral regurgitation.

Main Results:

• The pump-controlled retrograde trial off protocol served as a fail-safe method, allowing a stress test of cardiorespiratory reserve.
• The protocol was standardized, consistently performed, and enabled multiple weaning attempts with reduced circuit clotting risk.
• The protocol successfully predicted successful separation from VA-ECMO in the presented case.

Conclusions:

• The pump-controlled retrograde trial off protocol is a feasible, consistent, and valid alternative to traditional VA-ECMO weaning methods.
• This standardized approach enhances patient safety during VA-ECMO weaning and decannulation.
• The protocol facilitates accurate assessment of a patient's readiness for separation from VA-ECMO.